Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/10/26 21:46 | 2/6/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Schmid Timothy | NJ | O | EVP,WW C | 1 | M.d | 1,586 | 101.87 | 0 | 16 | 212 | 23 | D | ||||||||||||||
2/9/26 19:42 | 2/6/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Mulholland Kristen | NJ | O | EVP,CHRO | 1 | M.d | 573 | 101.87 | 0 | 6 | 52 | 16 | D | ||||||||||||||
2/9/26 19:40 | 2/6/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Wengel Kathryn E | NJ | O | EVP,Chie | 1 | M.d | 3,967 | 101.87 | 0 | 39 | 58 | 106 | D | ||||||||||||||
2/6/26 17:46 | 2/5/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Forminard Elizabeth | NJ | O | EVP,GC | 1 | M.d | 1,155 | 129.51 | 0 | 9 | 135 | 16 | D | ||||||||||||||
1/28/26 18:07 | 1/26/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Duato Joaquin | NJ | DO | CEO,CB | 1 | S | -22,123 | 221.23 | 0 | -100 | 308 | I | |||||||||||||||
12/1/25 16:15 | 11/26/25 | JNJ | Health | Drug | Pharmaceutical Preparations | Morikis John G | NJ | D | 1 | P | 258 | 206.15 | 0 | 1 | 209 | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |